Natalizumab in Crohn's disease: Results from a US tertiary inflammatory bowel disease center

Atsushi Sakuraba, Kian Keyashian, Chase Correia, John Melek, Russell D. Cohen, Stephen B. Hanauer, David T. Rubin

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Natalizumab in Crohn's disease: Results from a US tertiary inflammatory bowel disease center'. Together they form a unique fingerprint.

Medicine & Life Sciences